Testing a red blood transfusion approach during ECMO
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This study looks at whether giving red blood cell transfusions in a specific way is practical and safe for people receiving ECMO (a heart-lung support machine). It’s mainly a feasibility study, meaning the goal is to see if the plan can be carried out smoothly and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and are currently on ECMO
- You do not have a reason you cannot receive red blood cell transfusions
- You should not be on ECMO longer than 12 hours when the study would start
- Your care team expects ECMO to last past the near term (not stop before the end of tomorrow)
- You are not being kept from participating by personal wishes or care-team limits
- You are not currently listed for a solid organ transplant and you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a higher or lower threshold for red blood cell transfusions is better for people on ECMO (a heart-lung machine). It aims to find the safest way to manage transfusions during ECMO treatment.
This study looks at how platelets (the cells that help clot blood) behave in patients on a lung-support machine called ECMO. By taking blood samples, researchers hope to better understand clotting issues that can occur during ECMO support.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This trial tests whether giving more or fewer red blood cell transfusions is better for adult patients on ECMO (a machine that helps your heart and lungs work). The goal is to find the best transfusion approach to improve outcomes.
This trial tests whether using a measure of oxygen in your body can guide doctors on when to give you a blood transfusion. It may help avoid unnecessary transfusions while ensuring you get enough oxygen.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
Hear when a new Extracorporeal Membrane Oxygenation Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.